Case report of patient with infantile-onset Pompe disease treated with alglucosidase alfa beginning at age 16

被引:0
|
作者
Phalin, Judith [1 ]
Powell, Berkley R. [2 ]
Winter, Susan C. [2 ]
机构
[1] Childrens Hosp Cent Colif, Madera, CA USA
[2] Univ Calif San Francisco, San Francisco, CA 94143 USA
关键词
D O I
10.1016/j.ymgme.2007.08.074
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
69
引用
收藏
页码:S26 / S27
页数:2
相关论文
共 50 条
  • [1] Sudden deterioration in nonclassical infantile-onset Pompe disease responding to alglucosidase alfa infusion therapy: A case report
    Pascual-Pascual, S. I.
    Rubio, P.
    Albajara, L.
    Gutierrez, M.
    Chabas, A.
    Alvarado, F.
    [J]. JOURNAL OF INHERITED METABOLIC DISEASE, 2006, 29 (06) : 763 - 763
  • [2] Mini-COMET: effects of avalglucosidase alfa on ptosis in participants with infantile-onset Pompe disease previously treated with alglucosidase alfa
    Prakalapakorn, S. Grace
    Davison, James
    Broomfield, Alexander
    Kronn, David
    Labarthe, Francois
    Brassier, Anais
    Hahn, Si Houn
    Kumada, Satoko
    Ohki, Hirotaka
    Pichard, Samia
    Haack, Kristina An
    Johnson, Judith
    Meng, Xianzhang
    Chien, Yin-Hsiu
    Kishnani, Priya
    [J]. MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S137 - S137
  • [3] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
    V. Gragnaniello
    S. Fecarotta
    A. Pecoraro
    A. Tarallo
    A. Catzola
    G. Spadaro
    G. Parenti
    R. Della Casa
    [J]. Neurological Sciences, 2019, 40 : 1453 - 1455
  • [4] A CASE OF SUCCESSFUL DESENSITIZATION TO ALGLUCOSIDASE ALFA IN A 7 WEEK-OLD WITH INFANTILE-ONSET POMPE DISEASE.
    Adkins, C.
    Makris, C. M.
    Kankirawatana, S.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2014, 113 (05) : A25 - A25
  • [5] Desensitization of two young patients with infantile-onset Pompe disease and severe reactions to alglucosidase alfa
    Gragnaniello, V.
    Fecarotta, S.
    Pecoraro, A.
    Tarallo, A.
    Catzola, A.
    Spadaro, G.
    Parenti, G.
    Della Casa, R.
    [J]. NEUROLOGICAL SCIENCES, 2019, 40 (07) : 1453 - 1455
  • [6] Mini-COMET: Safety and efficacy of ≥97 weeks' avalglucosidase alfa in infantile-onset Pompe disease participants previously treated with alglucosidase alfa
    Kronn, David
    Davison, James
    Brassier, Anais
    Broomfield, Alexander
    Hahn, Si Houn
    Kumada, Satoko
    Labarthe, Francois
    Ohki, Hirotaka
    Prakalapakorn, S. Grace
    Haack, Kristina An
    Meng, Xianzhang
    Sparks, Susan
    Tammireddy, Swathi
    Wilson, Catherine
    Zaher, Atef
    Zhou, Tianyue
    Chien, Yin-Hsiu
    Kishnani, Priya
    [J]. GENETICS IN MEDICINE, 2022, 24 (03) : S348 - S349
  • [7] Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe Registry
    Kishnani, Priya S.
    Kronn, David
    Suwazono, Shugo
    Broomfield, Alexander
    Llerena, Juan
    Al-Hassnan, Zuhair Nasser
    Batista, Julie L.
    Wilson, Kathryn M.
    Periquet, Magali
    Daba, Nadia
    Hahn, Andreas
    Chien, Yin-Hsiu
    [J]. ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)
  • [8] Higher dose alglucosidase alfa is associated with improved overall survival in infantile-onset Pompe disease (IOPD): data from the Pompe Registry
    Priya S. Kishnani
    David Kronn
    Shugo Suwazono
    Alexander Broomfield
    Juan Llerena
    Zuhair Nasser Al-Hassnan
    Julie L. Batista
    Kathryn M. Wilson
    Magali Periquet
    Nadia Daba
    Andreas Hahn
    Yin-Hsiu Chien
    [J]. Orphanet Journal of Rare Diseases, 18
  • [9] Infantile-Onset Pompe Disease
    Ashrafi, Mahmoud Reza
    Tavasoli, Alireza
    [J]. IRANIAN JOURNAL OF CHILD NEUROLOGY, 2012, 6 (04) : 7 - 9
  • [10] A Multi-Centre Prospective Study of the Efficacy and Safety of Alglucosidase Alfa in Chinese Patients With Infantile-Onset Pompe Disease
    Zhu, Diqi
    Zhu, Jiacong
    Qiu, Wenjuan
    Wang, Benzhen
    Liu, Lin
    Yu, Xiaodan
    Ou, Zhenheng
    Shan, Guangsong
    Wang, Jian
    Li, Bin
    Chen, Xiaokang
    Liu, Cong
    Li, Zipu
    Fu, Lijun
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13